The critical interplay between estrogen signaling and AD strongly matches with emerging data on estrogen receptor genes, cognitive decline, and AD dementia in postmenopausal women, giving a compelling narrative for the potential of estrogen as a neuroprotective agent [25]. The gene discussed is ESR1; the disease is Mental deterioration.